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Abstract
Spherical nanoparticles (NPs) of cadmium and lead sulfides (diameter 37+ 5 and 24+ 4 nm, respectively) have been found to be
cytotoxic for HL-1 cardiomyocytes as evidenced by decrease in adenosine triphosphate–dependent luminescence. Cadmium
sulfide (CdS)-NPs were discovered to produce a much greater cytotoxic impact than lead sulphide (PbS)-NP. Given the same
dose range, CdS-NP reduced the number of calcium spikes. A similar effect was observed for small doses of PbS-NP. In addition to
cell hypertrophy under the impact of certain doses of CdS-NP and PbS-NP, doses causing cardiomyocyte size reduction were
identified. For these 3 outcomes, we obtained both monotonic “dose–response” functions (well approximated by the hyperbolic
function) and different variants of non-monotonic ones for which we found adequate mathematical expressions by modifying
certain models of hormesis available in the literature. Data analysis using a response surface linear model with a cross-term
provided new support to the previously established postulate that a diversity of types of joint action characteristic of one and the
same pair of damaging agents is one of the important assertions of the general theory of combined toxicity.
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Introduction
Experimental modeling of the cytotoxicity of element and
element-oxide nanoparticles (NPs) on cell cultures (most
often cultures of established cell lines) has been widely used
over many years in nanotoxicological studies1-7 and a great
number of others. The absolute majority of these studies con-
sider one particular NP species. Only some of them assess
comparatively the effects of 2 or more chemically different
NP species.6,7
However, to the best of our knowledge, we were the first8 to
publish the results of modeling (both in vitro and in silico) not
only the comparative but also the combined cytotoxicity of a
pair of NPs (specifically, NiO-NP and Mn3O4-NP). Moreover,
we performed our study on several human cell lines and
assessed the cytotoxic action in relation to both nonspecific
effects and effects that are specific to one of the lines only.
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The second such study was conducted on human fibroblast-like
cells under the impact of lead-oxide-NP and copper oxide-NP,
each alone or both in a combination.9
One of the principal conclusions following from both these
studies states that the types of binary combined cytotoxicity are
not uniquely defined (depending on the type of cell, its func-
tional condition, and index assessed) as is the case with organ
and system toxicity characterized in animal experiments10 and
others.
Metal nanotoxicology has drawn growing attention recently
not only because engineered NPs are manufactured for various
applications but also because condensation aerosols generated
by arc welding, metallurgy, laser, and other technologies usu-
ally contain a substantial fraction of nanoscale (ultrafine) par-
ticles in the overall particle size distribution. In all such
instances, workers are usually exposed to different combina-
tions of metal-containing NPs rather than to single NP spe-
cies.11 Therefore, while continuing to use cellular models,
experimental nanotoxicology cannot but expand research into
the issue of combined effects of particles not only in vivo but
also using such models.
By way of pursuing further research along this line, we
decided to choose as our next object of study the combination
of lead and cadmium NPs as typical of harmful exposures in
copper smelting industry. The test system of choice for expo-
sure was NP incubation with cells pertaining to the cardiovas-
cular system, in particular with various cardiomyocyte lines.
The rationale for this choice is the fact that the relationship
between occupational or environmental exposures to lead and
cadmium (irrespective of their chemical or physical form) and
different cardiovascular diseases or conditions has been a topi-
cal issue over decades, still widely discussed but still far from a
unanimous resolution. We would not like to overload this Intro-
duction section with a relevant literature overview, even a brief
one. The reader is referred to a recent paper that contains such
an overview as well as the authors’ new experimental (in vivo)
data on the issue under study.12
There are few published studies demonstrating effects of
any NPs on cardiomyocytes. In addition to cytotoxicity,
reduced contraction amplitudes (with TiO2-NPs
13), enhanced
beating properties (with mesoporous SiO2-NPs
14), interference
with ion channels (with Pt-NPs15), and increased Ca2þ spikes
and local Ca2þ flux (chitosan NPs16) have been reported. The
2016 overview devoted specially to NPs that cardiotoxicity
considers such NP species as zinc, titanium, silver, carbon,
silica, and iron oxide but does not mention lead or cadmium
in any chemical form.17
Study of adult cardiomyocytes physiology presents difficult
because isolated cardiomyocytes do not divide in culture.
Furthermore, yields are usually low, which is due to the high
sensitivity to hypoxia and to enzymatic digestion of the cells
and testing of many samples is difficult.18 Although embryonic
stem cells and induced pluripotent stem cells are able to differ-
entiate into cardiomyocytes in vitro, the efficiency of this pro-
cess is low. Primary explant cultures are heterogeneous and
often show poor reproducibility in toxicity testing.19
Embryonic and neonatal rat cardiomyocytes lack many fea-
tures of adult cardiomyocytes. Moreover, within a few days,
embryonic cardiomyocytes cease to divide after the neonatal
period. The use of murine embryonic stem cells, as alternative
model, presents the problem that no highly enriched popula-
tions can be obtained. Cessation of cell division is another
problem.20 Repolarization mechanism differs enormously
between species, particularly between small laboratory rodents
and humans. Therefore, the use of human-induced embryonic
or pluripotent stem cells is the most recommended model for
identification of cardiotoxicity in humans in vitro. The limita-
tion is that the low yields of cells do not enable high-throughput
testing.
Keeping in mind all these difficulties, we have chosen for
our experiment a cardiac muscle cell line HL-1 cells which,
even though not reflecting adequately the physiology of human
adult cardiomyocytes, still are established as a usable example
for the testing of cardiotoxicity.
The present article describes the first experimental study
into the in vitro comparative and combined cardiotoxicity of
lead- and cadmium-containing inorganic NPs and mathemati-
cal treatment of its results.
Materials and Methods
Preparation and Characterization of NPs
Suspensions of NPs were prepared by laser ablation of 99.9%
pure cadmium sulfide (CdS)-NP and lead sulphide (PbS)-NP
targets in deionized water with concentration 0.05 mg/mL. The
scanning electron microscope (SEM) Merlin (Carl Zeiss, Ger-
many) was used for direct visualization of NPs. Nanoparticles
of both types were mostly of irregular but close to spherical
shape (Figure 1). The size distribution functions were obtained
by a statistical analysis of SEM images of 250 CdS NPs and
450 PbS NPs. The mean diameters were determined to be 37+
5 nm for CdS-NP and 24 + 4 nm for PbS-NP (Figure 2).
Energy-dispersive X-ray spectroscopy performed in conjunc-
tion with SEM showed the chemical composition of the NPs to
be exactly CdS-NP and PbS-NP.
The absence of any noticeable changes in the zeta potential
as well as in the shape and position of the plasmon resonance
peak 2 weeks after suspension preparation confirmed the satis-
factory stability of the suspensions.
Nanoparticle solubility in a liquid medium was estimated by
the kinetics of concentration reduction measured by the method
of optical photometry with the help of a double-beam
high-performance spectrophotometer Cary 5000 (Agilent
Technologies, Santa Clara, California, United States). The
NP suspension was mixed with a liquid (water or Claycomb
medium) in 1:1 ratio. The differences between the transmission
spectra of this mixture and the liquid without particles were
measured in a spectral wavelength range of 200 to 800 nm in
certain intervals. Characteristic changes in the spectra were
observed in a spectral range of 230 to 280 nm. Numerical
integration of the spectra was carried out in this range. The
2 Dose-Response: An International Journal
integral intensity of the signal was proportional to the concen-
tration of NPs in the solution.
Cell Line Characterization, In Vitro Exposure Technique
and Parameters, and Cytotoxicity Estimates
Experiments were implemented on HL-1 cells derived from the
AT-1 mouse atrial cardiomyocyte tumor lineage characterized
in.21 This established line had been described as mitotically
active cardiac muscle cells showing highly ordered myofibrils
and cardiac-specific junctions in the form of intercalated discs.
They are able to undergo spontaneous contractions and express
atrial natriuretic factor, a-myosin heavy chain, a-cardiac actin,
desmin, and connexin 43. Furthermore, they present several
voltage-dependent currents that are characteristic of the cardiac
myocyte phenotype.
HL-1 cells have been used for studying the normal cardio-
myocyte function with regard to signaling, electrical, meta-
bolic, and transcriptional regulation and the reaction of
cardiomyocytes to hypoxia, hyperglycemia–hyperinsulinemia,
apoptosis, and ischemia–reperfusion.20 They have also been
used in in vitro models to study cardiac hypertrophy induced
by aldosterone22 and by endothelin-1 or norepinephrine,23 with
the upregulation of cardiotrophin-1 identified as its mechan-
ism.22 To study cardiac hypertrophy, HL-1 cells have to be
precultured in a depleted medium because the routine medium
for enabling spontaneous beating contains norepinephrine,
which is a hypertrophic stimulus.24
For our experiments, HL-1 cells were obtained from Sigma
Aldrich and cultured in Claycomb medium (Sigma), 10% fetal
bovine serum, 2 mM L-glutamine, 100 mM norepinephrine, and
1% penicillin/streptomycin and maintained at 37C in a 5%
CO2 atmosphere. The maximal concentration that was evalu-
ated in the assays was based on the effect of the respective
solvent control (water). If the reaction by addition of water was
significantly changed compared to the reaction in medium, this
NP concentration could not be assessed. Based on this limita-
tion, the maximum concentration that was evaluated for PbS-
NP was 7.5 mg/mL and did not induce cytotoxicity.
Choosing cytotoxicity indicators. As well as in our previous studies
mentioned above,8,9 we were primarily interested in estimating
quantitatively the nonspecific cytotoxicity of the NP species
under study for the cells of the line used. Of the various assays
that were available for this assessment and, in particular, used
by us previously, we opted for the measurement of adenosine
Figure 2. NP size distribution functions for (A) CdS-NPs and (B) PbS-NPs. CdS-NP indicates cadmium sulfide nanoparticles; PbS-NPs, lead
sulphide nanoparticles.
Figure 1. Scanning electron microscope visualization of (A) CdS-NPs and (B) PbS-NPs. CdS-NPs indicates cadmium sulfide nanoparticles; PbS-
NPs, lead sulphide nanoparticles.
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triphosphate (ATP)–dependent luminescence in cell culture.
Like any other indicator used for a similar purpose, this assay
provides reference points for selecting an appropriate dose
range in which to identify the functional effects of exposure
that are specific to the cardiomyocyte. At the same time, it is
particularly relevant to the study of cardiotoxicity mechanisms
because it has been shown that under subchronic lead intoxica-
tion, the in vitro contractile activity of muscle preparations
extracted from rat myocardium undergoes a number of essen-
tial changes.25 Meantime, one of the possible hypotheses con-
cerning the mechanisms of decreased cardiomyocyte
contractility under different NP impacts might be decreased
ATP levels due to mitochondrial damage and dysfunction.26
As concerns the effects of NP exposure which might be
considered really specific to cardiomyocytes, we sought to
identify possible changes in 2 indices: mean cell size and fre-
quency of Ca2þ spikes.
Although cardiac hypertrophy in vivo may occur as an adap-
tion to changes in vascular resistance (including those induced
by lead intoxication12), it is highly interesting to see whether it
can also be due to damage in the cardiomyocyte caused by
toxic metals in the form of NPs. Meantime, as far as we know,
the effects of any NPs on cardiomyocyte hypertrophy in vitro
have not yet been studied.
The so-called calcium spikes occur in response to each electric
stimulus applied to the cardiomyocyte. They reflect the Ca2þ
transient, that is, the balance of various Ca2þ ion flows into and
out of the cytosol and their binding by intracellular ligands. The
main flow into the cytosol comes from the intracellular calcium
depot in the sarcoplasmic reticulum (SR). Calcium is transferred
back into the SR against the concentration gradient at the expense
of the energy derived from ATP hydrolysis by the Ca2þ-ATPase
located in the SR membrane. The main intracellular calcium-
binding ligand is troponin C, protein distributed along the actin
filaments of the sarcomere. When calcium–troponin complexes
form, centers for the attachment of force-generating myosin
cross-bridges are opened on the actin. Thus, free calcium in the
cytosol represented by the Ca2þ transient is the principal dynamic
regulator of cardiomyocytes contractile activity.27,28
Experimental techniques
Adenosine triphosphate assay. 4 104 HL-1 cells per a well of
96-well plates were seeded 24 hours prior to their exposure to
NPs either in complete Claycomb medium or in a depleted
medium as used for hypertrophy measurements (see below). Par-
ticle suspensions were acting on the cells for 24 hours. As positive
control, 1% triton X100 was used. In addition, interference con-
trols (particles without cells) and solvent controls (water) were
included. Adenosine triphosphate content was determined using
CellTiter-Glo Luminescent Cell Viability Assay (Promega,
Madison, Wisconsin, USA) according to the manufacturer’s
instruction. The plates were equilibrated to room temperature for
approximately 30 minutes, and reconstituted CellTiter-Glo
Reagent was added 1:1 to the amount of cell culture medium
present in each well. The plates were shaken for 2 minutes and
incubated for additional 10 minutes at room temperature before
transferring the well contents to a luminescence compatible 96-
well plate, and luminescence expressed in arbitrary fluorescence
units (AFU) was read on a Lumistar (BMG LabTech, Germany).
Testing was performed in triplicates.
Hypertrophy measurements. HL-1 cells were grown in Clay-
comb medium without norepinephrine for 14 days to induce
their responsibility to hypertrophic agents according to.23 3 
104 HL-1 cells were seeded in 24-well plates 24 hours prior to
the experiments and exposed to samples and positive controls
(100 nM endothelin 1 and 10 mM norepinephrine, Sigma
Aldrich) for 18 hours. Medium-exposed cells served as nega-
tive control. CellMask deep red plasma membrane stain (Life
Techologies, Poggersdorf, Austria) and Hoechst 33342 were
added for 10 minutes at 37C, and cells subsequently fixed
with 4% paraformaldehyde for 10 minutes. Staining was per-
formed according to the manual of the manufacturer. Analysis
was performed with Nikon NIS Elements software.29
Cells were viewed at confocal high content screening sys-
tem (Nikon CEE GmbH, Austria) with 395 nm/414 to 450 nm
for Hoechst 33342 and 640 nm/660 to 850 nm for CellMask.
Images were analyzed using NIS Elements software with JOBS
module. Experiments were performed in triplicates, and 4
fields of view (¼ 1 827 038 mm2) were analyzed per sample.
Cellular area/cell was measured.
Detection of calcium spikes. In this technique, intracellular
calcium fluxes are visualized by fluorescent reporter dyes,
ratiometric calcium indicators like the Fura dyes or nonratio-
metric dyes such as the fluorescent dyes. All these indicators
have slight adverse effects on cell physiology, but we chose the
EarlyTox Cardiotoxicity Kit from Molecular Devices (San-
Jose, California, USA), which was reported to be less toxic
than the conventional dyes.
1  105 HL-1 cells were seeded per well of 96-well plate 24
hours prior to the exposure. Samples in different dilutions and
positive control (40-mM propranolol hydrochloride, VWR, Rad-
nor, Pennsylvania, USA) and EarlyTox Cardiotoxicity Kit
(Molecular Devices, San-Jose, California, USA) were added for
2 hours at 37C according to the manufacturer’s protocol.30
Spontaneous calcium transients were captured in single cells at
Ex 470 nm/Em 500-530 nm for 30 seconds using a Nikon high
content screening system (Nikon CEE GmbH) prior and after the
addition of samples and positive control. After subtraction of the
background, the number of spikes (only those with amplitudes
>30 AFU) per 30 seconds was manually counted before and after
the treatment.31 Testing was performed in triplicates.
Mathematical Description of the Experimental Results
The first step in the formal analysis of the above-described
experiments was a search for analytical dependence of the
effect on dose. Such mathematical modeling is often used not
only as one of the preconditions to discussion of toxicodynamic
mechanisms but also for tentative prediction of the effects a
poison could produce in dose ranges that were not used in the
actual experiment.
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However, the experimental data were obtained in 2 experi-
ments of different design, so they need to be considered sepa-
rately. On the one hand, these are data on the exposure of the
cell culture to CdS-NP and PbS-NP separately, recorded by 3
different indices considered in section “Cell Line Characteriza-
tion, In Vitro Exposure Technique and Parameters, and Cyto-
toxicity Estimates.” On the other hand, these substances were
studied for their combined action as well, which requires spe-
cial methods for their mathematical description.
Mathematical description of an impact produced by a single
agent means approximating the dose–response relationship for
a certain specific end point of this impact by a function of one
variable, that is, dose of the agent. A combined action should be
described by a similar function depending on the doses of both
substances involved.
For both isolated and combined impacts, the choice of an
appropriate approximation presents a difficult nonformalizable
problem; however, for demonstrating how successfully it has
been resolved, one can estimate the quality of the approxima-
tion, for example, the correlation coefficient R between
observed and expected response values. For dose–response
models, this may also be visually shown as charts comparing
the positions of the group-mean values of the response to all
experimental doses relative to the approximating curve.
Modeling the dose–response dependence with special attention to
possible hormesis. The dose–response dependence is often of a
monotonic character and is described by an S-shaped curve32
(sigmoid function). The analytical expression of this depen-
dence may be represented, for example, by the Hill model, as
well as by many other models, for instance, those associated
with cumulative probability distribution functions (eg, logistic,
error, and probit functions). The Hill model is also connected
with probability distribution since the right-hand part of equa-
tion (1) is proportional to the cumulative function of the log-
logistic distribution33-35:
f x; b0; b1; b2; b3ð Þð Þ ¼ b0 þ b1
1þ b2xð Þb3
: ð1Þ
Furthermore, for describing a monotonic case, often a suffi-
ciently good approximation is ensured by a simple hyperbolic
function of the form:
y ¼ b0 þ b1x
b2 þ b3x : ð2Þ
An interesting feature of this model is that it presents a more
general expression of the Michaelis–Menten equation, which
describes the rate of enzymatic reactions.36 Equation (2) is
different from the Michaelis–Menten equation in that it con-
tains a term b0, which is determined by the presence of a non-
zero value of the response in the untreated group (control).
Clearly, the hyperbolic model (2) may be represented as a
Michaelis–Menten equation by just shift of the response by the
amount of the control group’s value and, possibly, by reversing
the sign.
Note also that the hyperbolic model (2) itself has a number
of applications in constructing the dependence of biological
indicators on various parameters.37 It is well known, however,
that the response of a biological system to a relatively low and
high level of impact could be directed oppositely.38 With ref-
erence to dose-dependent pharmacological and toxicological
effects, this paradox was formulated as the so-called Arndt-
Schulz rule, which states that “for every substance, small doses
stimulate, moderate doses inhibit, large doses kill.” As is
known, this statement served as a theoretical foundation for
homeopathy, although it aroused powerful and unrelenting cri-
ticisms among scientists.39-42
The further development of these ideas was associated with
the work,43 in which the term hormesis was proposed for the
first time. Since then, it has been widely known as one of the
conceptual models for the response of the organism to external
impacts. It should be noted, however, that the real effects of
hormesis are less sustainable and reproducible than typical
unambiguous dose-dependent effects of an impact. Moreover,
mechanisms underlying such paradoxical effects cannot always
be explained rationally.
The most popular conception of hormesis is its abovemen-
tioned interpretation as a stimulating effect of small doses in
contrast to the inhibiting effect of high ones. However, it is not
always clear which effect is favorable and which one is
adverse. This question was effectively circumvented by the
following generalized definition: “Hormesis is a dose-
response relationship for a single end point that is characterized
by reversal of response between low and high doses of chemi-
cals, biological molecules, physical stressors, or any other
initiators of a response.”42(p238)
Different forms of analytical representation of hormetic
dose–response relationships have been presented in an exten-
sive body of literature.44-51 The expressions used in these stud-
ies for approximating experimental data adequately are
sometimes rather complicated depending on the results of a
specific study. An impression arises that there is, in principle,
no mathematical model such that would be applicable in all or,
at least, in the majority of cases where hormesis is discovered
in particular experiments.
The simplest model for describing hormesis seems to be the
one by Brain and Cousens,49 which is obtained by adding a
dose-linear term into equation (1), giving:
y ¼ b0 þ b1 þ b2x
1þ b3xð Þb4
: ð3Þ
This model is known to have numerous modifications, over-
viewed, for example.47 Thus, in particular, the study50 presents
a more complex model based on equation (3), which can over-
come some of the limitations of model (3). The equation of this
model is given by:
y ¼ b0 þ
b1 þ b2exp 1=xb3
 
1þ b4xð Þb5
: ð4Þ
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Nevertheless, there are cases for which none of these models
provides an acceptable result. We came across such a case
when analyzing some of our own experimental results and so
had to search for modified models that would enable us to solve
the problem.
First of all, we present here as an interim variant the follow-
ing model, which is a generalization of model (3) while remain-
ing, unlike equation (4), within the power law dependence:
y ¼ b0 þ b1 þ b2x
b3
1þ b4xð Þb5
: ð5Þ
Depending on the parameters of model (5), it describes var-
ious models of both monotonic and hormetic dependencies.
The modification (6) is also derived from the power law only,
being given by:
y ¼ b0 þ b1 þ b2x
b3
1þ b4xð Þb5
 !
1þ b6xb7
 
¼ b0 þ b0b6xb7 þ b1 þ b2x
b3 þ b1b6xb7 þ b2b6xb3þb7
1þ b4xð Þb5
:
ð6Þ
In some cases, equation (6) was found to be more conveni-
ent than the hormesis models available in the literature. How-
ever, a more detailed analysis showed that, along with model
(6), we had to consider the following one:
y ¼
b0 þ b1þb2xb31þ b4xð Þb5
1þ b6xb7 ¼
b0 þ b1 þ b0 b4xð Þb5 þ b2xb3
1þ b6xb7ð Þ 1þ b4xð Þb5
  ; ð7Þ
which may prove more adequate for the case where small doses
are associated with a decrease in the response rather than its
increase.
Algebraically, equations (6) and (7) have a simpler structure
than some other equations of hormesis, such as ones employing
Gompertz or Weibull distribution.46,47 The number of para-
meters to be adjusted in equations (6) and (7) is fairly large
(8!), which increases the flexibility of these models though
makes the interpretation of individual parameters more diffi-
cult. For instance, for model (3), the statistical test for the
presence of hormesis consists in checking the hypothesis H0:
b2 ¼ 0. If this hypothesis is true, there are no grounds to claim
that there is hormesis in the dose–response relationship. On the
contrary, for equations (6) and (7), the parameters that ensure
hormesis enter the equations in such a way that it is rather
difficult to unambiguously formulate conditions for coeffi-
cients that would guarantee the occurrence of a characteristic
hormetic curve. For instance, even if all coefficients b1, b2, and
b6 were positive and significantly different from 0, function (6)
could be monotonic, although with inflection points.
Models (6) and (7) are complex, and it is impossible to
obtain explicit expressions in general form for the effective
dosage reducing the response by 50% or any other percentage.
It is clear, though, that the magnitude of b0 þ b1 for both
models (6) and (7) is equal to the magnitude of the control
value of the response. Nevertheless, in each specific case where
equation (6) or (7) describes adequately the experimental data,
all essential values may be found numerically.
As a general case, of interest are the statistical properties of
estimates for the parameters b0, . . . , b7 in models (6) and (7),
for instance, joint confidence regions. Models (6) and (7)
describe a nonlinear regression whose parameters could be
estimated by standard tools.52 The need to perform calculations
using explicit formulas52 does not arise often because these
methods are implemented in standard statistical or general
mathematical packages (computer algebra systems). However,
where the conditions of applicability for these formulas are
violated, there may be a need to use alternative ways of asses-
sing the uncertainty of the resulting estimates. Among these
methods, we could mention bootstrap confidence intervals,53
prediction intervals with neural networks,54,55 and Bayesian
framework.56 All these methods also have realizations in some
computation systems, for instance, in the R statistical system.57
Modeling binary combined action. In our first study of combined
toxicity,58 we analyzed experimental results using different
mathematical models based on (1) analysis of variance and
(2) Mathematical Theory of Experimental Design, which cor-
respond to the well-known paradigms of effect additivity and
dose additivity (Loewe additivity), respectively. Having
proved that assignment of experimental results to this of that
type of combined toxicity is model-insensitive, in our further
studies beginning from the study by Panov et al,59 we used
mostly the Response Surface Methodology (RSM), which gen-
eralizes those traditional paradigms.60,61 In this methodology,
an equation (8) describing the response surface Y ¼ Y(x1, x2)
can be constructed by fitting its coefficients to experimental
data.
Y ¼ f x1; x2ð Þ; ð8Þ
where Y is a quantitative end point of a toxic exposure; x1 and
x2 are doses of the toxicants participating in the combination;
and f(x1, x2) is a regression function with some numeric para-
meters. In the case of 2-level exposures (even if one of the
levels is equal to 0), the nonlinear response surface may have
only one possible shape, namely, hyperbolic paraboloid.62 It is
inferred that 2 agents produce a unidirectional effect on end
point Y if both 1-way response functions Y(x1, 0) and Y(0, x2)
either increase or decrease with an increase in x1 or x2. On the
contrary, 2 agents are assumed to be acting contradirectionally
(oppositely) if one function increases while the other decreases.
This mathematical model enables one to predict the magnitude
of response Y for any combination of toxicant doses within the
experimental range for each of them (rather than at 2 factual
points only). The sectioning of the response surface on differ-
ent levels corresponding to different meanings of the outcome
Y or of the doses x provides a family of Loewe isoboles that
may have one and the same or different forms and/or different
slopes and thus render the interpretation of binary combined
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toxicity types both easy and illustrative. We, therefore, discuss
the results of analysis presented just in this form.
Results and Discussion
Cardiotoxicity is an important dose-limiting side effect of var-
ious anticancer agents and one of the leading causes of drug
withdrawals. The best-known examples for cardiotoxic drugs
include anthracyclines (eg, doxorubicin), 5-fluorouracil, tax-
anes (eg, paclitaxel), monoclonal antibodies (eg, trastuzumab),
and tyrosine kinase inhibitors63 (eg, sunitinib). The current
recommended procedure by the US Food and Drug Adminis-
tration is to identify potential cardiotoxic drugs in vitro using
the human ether-a-go-go–related gene (hERG) assay, which is
performed with nonmyocyte HEK293 cells. The cells are trans-
fected with the gene that encodes the pore-forming subunit of
the rapidly activating delayed rectifier Kþ channel (IKr), which
plays an important role in the repolarization of cardiac action
potentials.64 The assays used in this study may also be useful as
alternative testing methods in preclinical drug development.
Dose–Response Relationships for Single-Factor
Exposures
Decrease in ATP-dependent luminescence. The experimental data
on the relationship between ATP-dependent luminescence
decrease in a culture of cardiomyocytes and CdS-NP dose are
of a usual monotonic character, which can be approximated by
many functional expressions. As well as in our previous stud-
ies,8,9 in this case, too, we found the most suitable approxima-
tion to be a hyperbolic function of the form (2), the parameters
of which are fitted by the least squares method. For this end
point, expressed as a percentage relative to the control value
rather than in absolute AFU, model (2) predicts the kinetics of
its decrease shown by the curve in Figure 3.
As follows from the chart, the approximating curve
describes the change in the AFU index quite well, demonstrat-
ing a sharp drop in it toward the maximal dose of the range
tested at 3.75 mg/mL.
For the second agent PbS-NP, however, the behavior of the
relative value of AFU looks quite different (Figure 4). The
sharp drop in the magnitude of the response at a dose of 0.9
mg/mL goes far beyond the level of a possible error in contrast
to the 3 next doses, for which the standard error ranges overlap.
Note, however, that even if we did not consider the value of
Y at x¼ 0.9 mg/mL, the fact that the response level exceeds the
control group value at subsequent doses excludes the possibil-
ity of describing the dependence of AFU on PbS-NP dose
monotonically. It may be expected that as the dose of PbS-
NP is increased, the response would decrease and then stabilize
at a certain value. In other words, for PbS-NP¼ 0.9 mg/mL, the
behavior of the response is opposite to its behavior at higher
doses, manifesting signs of hormesis.
Thus, for describing the dose–response dependence of the
relative value of AFU on exposure to PbS-NP, it is necessary to
use one of the models of nonmonotonic dependence. As
computations showed, none of the models that we found in the
literature41-50 provided a satisfactory description of the
assumed dependence. At the same time, model (7) proves to
be quite suitable (see Figure 5).
For comparing different hermetic curves, we can use quan-
titative indicators proposed in65 (see also the study by Belz and
Piepho45). Knowledge of such general characteristics makes it
possible to compare various cases of hormesis, as was done in
the stusy by Calabrese and Blain.66 In our case, these charac-
teristics are as follows:
Figure 3. Approximation, by model (2), of the reduction in adenosine
triphosphate–dependent luminescence in the HL-1 cell culture under
exposure to various doses of CdS-NP. The abscissa plots the acting
concentrations of nanoparticles in the incubation medium, milligram
per milliliter; the ordinate plots the values of the arbitrary fluores-
cence units index in the exposed group as a percentage of the control
value. The dots indicate the mean values with the standard error of
the mean. CdS-NPs indicates cadmium sulfide nanoparticles.
Figure 4. Group-mean values of adenosine triphosphate–dependent
luminescence in the HL-1 cell culture under exposure to various doses
of PbS-NP. The abscissa plots the concentrations of nanoparticles in
the incubation medium, milligram per milliliter; the ordinate plots the
values of arbitrary fluorescence units in the exposed group as a per-
centage of the control group value. The dots indicate the mean values
with the standard errors of the mean. PbS-NPs indicates lead sulphide
nanoparticles.
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Zones of hormesis: 0.12 to 0.65 mg/mL and 2.90 to 3.66 mg/
mL. (For computation, we used the value of 90% of the control
for the region before 0.9 mg/mL and 110% of the control for
the region after 0.9 mg/mL.)
Minimal response : 85:97 at PbS NP
¼ 0:32 mg=mL 86% of controlð Þ
Maximal response : 110:16 at PbS NP
¼ 3:25 mg=mL 110% of controlð Þ
It should be emphasized that in the case under consider-
ation, the order of alternation of the first 2 phases in the
dose–response relationship (first toward reduction in lumi-
nescence and then, at medium range doses, toward its sti-
mulation) contradicts the Arndt-Schulz rule and thus the
most popular understanding of hormesis; however, it is in
agreement with its more generalized definition42 cited in the
Introduction section.
At the same time, model (7) predicts a secondary drop in the
response not only in the actual range of doses from 3.75 to 7.5
mg/mL, for which it was really shown in our experiment, but
also for their subsequent increasing. The latter requires an
experimental verification and, particularly, an attempt to com-
prehend the toxicological meaning and possible mechanisms of
such a paradoxical dose–response relationship.
We are aware of only 2 experimental studies67,68 which
report a similar 3-phase dependence (enhancement, attenua-
tion, secondary enhancement) of apoptosis in zebrafish
embryos on the dose of proton irradiation. Thus, such depen-
dence really exists, although it does not seem to be encountered
that often. It is probably therefore that we have not found any
theoretical discussions of it in the publications on hormesis in
general that are known to us. Note, in particular, that the
possibility of alternating changes of direction in the response
with an increase in dose is not even mentioned in the defini-
tions of hormesis referred to in the Introduction section.
We may assume that the development of even one and the
same end point of intoxication may have different underlying
mechanisms, one or another of them prevailing at different
exposure levels (doses). For instance, the impact of metallic
NPs on the ATP content of a cell culture may be associated
both with a 2-phase impact on the level of oxidative phosphor-
ylation controlled by mitochondria (note 1) and with the reduc-
ing number of viable cells. The latter prevails at high doses of
PbS-NP and even at much lower doses of more cytotoxic CdS-
NP. Indeed, based on the equations used for describing the
dependence of the cytotoxic effect on the concentration of NPs
in the incubation medium, we estimated the moderately effec-
tive exposure as one for which 50% inhibition of ATP-
dependent luminescence should be expected. It proved to be
equal to 3.6 mg/mL for CdS-NP (note 2) and 153.97 mg/mL for
PbS-NP. Possibly, the higher cytotoxicity of CdS-NP is partly
associated with their markedly higher dissolution in the
incubation medium, which is shown in a special experiment
(Figure 6).
Note, however, that comparative animal experiments with
preformed solutions of cadmium and lead salts also revealed a
considerably higher subchronic systemic toxicity and cardio-
toxicity of cadmium.12
Inhibition of calcium spikes. For the index “number of calcium
spikes,” the behavior of the dose–response relationship under
exposure to CdS-NP (see Figure 7) is about the same as in the
above-considered relative value of AFU. In this case, there is
also a monotonically decreasing dependence, which is well
described by a simple hyperbolic function (2).
Regrettably, for the PbS-NP exposure, there are only 3 doses
available (including the control group), which does not allow
the dose–response relationship to be correctly represented in
the range of experimental doses. However, there are grounds to
assume that there is hormesis in this case (as well as in the case
of culture luminescence reduction); since in the dose range of 3
to 3.5 mg/mL, the response increases sharply while being
somewhat reduced under the action of smaller doses (see
Figure 8).
Effect on cardiomyocyte size. As well as in the case of the above-
considered indices, the effect of CdS-NP on the average area of
the cell in the range of 0 to 3.5 mg/mL is rather pronounced,
while for PbS-NP in the range of 0 to 7.5 mg/mL, it is markedly
weaker (Figures 9 to 11). For both agents, the sign of the
response is different for different dose ranges. Meanwhile, in
experiments in vivo12 involving moderate subchronic intoxica-
tions with the same metals in ionic form, lead caused a signif-
icant increase in the average thickness of the cardiomyocyte,
whereas cadmium caused a significant decrease in it with his-
tological signs of apoptosis.
In the in vitro experiment under consideration, the response
of the cardiomyocyte culture to the impact of CdS-NP was
Figure 5. Approximation, by model (7), of the reduction in adenosine
triphosphate–dependent luminescence in the HL-1 cell culture under
exposure to various doses of PbS-NP. The abscissa plots the concen-
trations of nanoparticles in the incubation medium, milligram per
milliliter; the ordinate plots the values of arbitrary fluorescence units
in the exposed group as a percentage of the control group value. The
dots indicate the mean values with the standard error of the mean.
PbS-NPs indicates lead sulphide nanoparticles.
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characterized by explicit hormesis, which manifested itself in
an increase in the mean size of the cell in response to small
doses of NPs and a decrease in its size in the medium range of
doses and a rather rapid stabilization of this index (Figure 9).
This behavior is sufficiently well approximated by model (3),
as well as by model (6), whose charts are about similar. (Figure
9 shows the approximation to the dose–response relationship
by model 3)
The characteristics of this hormesis curve are as follows:
Hormesis zone : 0 to 0:047 mg=mL
 ðmeasured from the control value since ED110
exceeds the maximum of the curveÞ
Maximal value of the response : 1931:13
for CdS NP ¼ 0:042 mg=mL; 109% of controlð Þ
Under exposure to PbS-NP (see Figure 10), the index rises
sharply at low doses and then decreases in the range of medium
doses. At the same time, we again (as well as for the ATP-
dependent luminescence) see that subsequent increasing of the
dose causes the response to rise again rather than reaching an
equilibrium value.
None of the mathematical models of hormesis that we found
in the literature provided a satisfactory approximation of the
data shown in Figure 10. At the same time, equation (6), which
we derived by modifying one of these models (see section
Figure 6. The kinetics of nanoparticle concentration reduction (CdS-NP on the left; PbS-NP on the right) in the suspension after adding an
equal volume of complete Claycomb medium to it. For the measurement procedure, see section “Preparation and Characterization of NPs.”
CdS-NPs indicates cadmium sulfide nanoparticles; PbS-NPs, lead sulphide nanoparticles.
Figure 8. The frequency of calcium spikes in the HL-1 cell culture
under exposure to various doses of PbS-NP. The abscissa plots the
acting concentrations of nanoparticles in the incubation medium, milli-
gram per milliliter; the ordinate plots the values of the index “number
of Ca2þ spikes with amplitudes >30 arbitrary fluorescence units per 30
seconds”). The dots show the mean values with the standard error of
the mean. PbS-NPs indicates lead sulphide nanoparticles.
Figure 7. Approximation, by model (2), of the decrease in the fre-
quency of calcium spikes in the HL-1 cell culture under exposure to
various doses of CdS-NP. The abscissa plots the acting concentrations
of nanoparticles in the incubation medium, milligram per milliliter; the
ordinate plots the values of the index “number of Ca2þ spikes with
amplitudes >30 arbitrary fluorescence units per 30 seconds”). The
dots indicate the mean values with the standard error of the mean.
CdS-NPs indicates cadmium sulfide nanoparticles.
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“Modeling the dose–response dependence with special atten-
tion to possible hormesis”), fits the experimental data perfectly
(Figure 11). A good data approximation was also provided by
equation (7):
Hormesis zone : 0:11 to 0:65; 1:33 to 4:39 mg=mLð Þ
Minimal response : 1419 for PbS NP
¼ 2:35 mg=mL 80% of controlð Þ
Maximal response : 2028 for PbS NP
¼ 0:34 mg=mL 115% of controlð Þ:
The fact that we found the 3-phase dose–response depen-
dence of this kind by 2 formal independent indices, in both
cases just for PbS-NP, is an argument for considering this see-
mingly paradoxical variant of hormesis as nonaccidental. Its
hypothetical toxicological interpretation was given in section
“Decrease in ATP-dependent luminescence.”
To conclude this section, we should mention that mean dia-
meters of NPs used in our experiment are rather close, and
therefore, the small difference between these sizes hardly can
be a cause of different toxicity outcomes. We believe that the
different types of dose–response relationship are due to differ-
ent chemical nature of these NPs.
Estimating the Type of Combined Action of CdS-NP and
PbS-NP on Cardiomyocyte Culture
As can be seen from the results of the RSM analysis presented
in the form of isoboles, all 3 recorded end points of combined
action, particularly ATP-dependent luminescence inhibition
(Figure 12), demonstrate the clear prevalence of CdS-NP action
(which is well explained by its higher cytotoxicity compared
with PbS-NP). However, at lower CdS-NP concentrations as
well, there is a trend toward an opposite action of PbS-NP
while at high concentration, on the contrary, to additivity of
the combined action produced by the 2 NP species.
According to the effects of reduction in calcium spikes
(Figure 13) and cardiomyocyte size (Figure 14), the unidirec-
tional action of both CdS-NP (in relatively high doses) and
PbS-NP is even more obvious, up to being superadditive in the
first case.
Numerous animal experiments carried out by the Ekaterin-
burg toxicological team by way of modeling the combined
action of various combinations of metal ions or metal-oxide
NPs10,11,12,58,59,71-76 have shown repeatedly that for one and the
same binary toxic combination, the type of combined toxicity
Figure 10. The values of cardiomyocyte area for experimental doses
under exposure to PbS-NP. The chart shows the mean values with the
standard error of the mean. The abscissa plots the nanoparticle con-
centrations in milligram per milliliter, and the ordinate plots the mean
value of the cell area in square micrometer. PbS-NPs indicates lead
sulphide nanoparticles.
Figure 11. Approximation, by model (6), of the dependence of the
mean cell size in the HL-1 culture under exposure to various doses of
PbS-NP. The abscissa plots the acting concentrations of nanoparticles
in the incubation medium, milligram per milliliter; the ordinate plots
mean cardiomyocyte area in square micrometer. The dots indicate the
mean values with the standard error of the mean. PbS-NPs indicates
lead sulphide nanoparticles.
Figure 9. Approximation, by model (3), of the dependence of the
mean cell size in the HL-1 cell culture under exposure to various
doses of CdS-NP. The abscissa plots the acting concentrations of
nanoparticles in the incubation medium, milligram per milliliter; the
ordinate plots the mean area in square micrometer. The dots indicate
the mean values with the standard errors of the mean. CdS-NPs
indicates cadmium sulfide nanoparticles.
10 Dose-Response: An International Journal
can vary from synergistic (superadditive) to contradirectional
depending on the outcome under consideration and its level.
This essential postulate of the theory of combined toxicity was
also confirmed in experiments on different cell cultures
exposed, alone or in combination, to NPs of manganese and
nickel oxides8 or lead and copper oxides.9 It should be stressed
that the typological ambiguity of the combined toxicity of cad-
mium and lead in ionic form was shown, in particular, under
subchronic intoxication of rats by a large number of end points,
including hemodynamic and electrocardiographic ones.12 We
believe that the experimental results considered in this paper
are in good agreement with all these previously obtained data
and strengthen the theoretical postulate formulated above.
Conclusions
Cadmium and lead sulfide NPs acting on the HL-1 line of
cardiomyocytes display cytotoxicity as judging by the decrease
in ATP-dependent luminescence, CdS-NP producing a consid-
erably stronger effect than PbS-NP (partly due to more active
dissolution of the former in incubation medium).
The CdS-NP in practically the same dose range as well as
small doses of PbS-NP reduced the number of spontaneous
calcium spikes, which is a specific effect for cells of this type
and can indicate a disturbance of the Ca2þ transient, the main
dynamic regulator of the contractile activity in the
cardiomyocyte.
Along with cell hypertrophy under the action of certain
doses of CdS-NP and PbS-NP, our experiment also revealed
doses causing a decrease of the cardiomyocyte size. We
obtained both monotonic (well approximated by the hyperbolic
function) and different variants of nonmonotonic “dose–
response” relationships, for which we managed to construct
adequate mathematical expressions by modifying some of the
Figure 13. Isobologram characterizing the combined toxic action of
CdS-NPs and PbS-NPs on the HL-1 cells culture as estimated by
change in the frequency of calcium spikes. Numbers at the axes are
respective MeS-NP concentrations in mg/mL, numbers at the isoboles
are the values of the effect to which they correspond. CdS-NPs indi-
cates cadmium sulfide nanoparticles; MeS-NP, mercaptoethanesulfo-
nate nanoparticle; PbS-NPs, lead sulphide nanoparticles.
Figure 14. Isobologram characterizing the combined toxic action of
CdS-NPs and PbS-NPs on the HL-1 cells culture as estimated by the
mean cardiomyocyte size in square micrometer. Numbers at the axes
are respective MeS-NP concentrations in mg/mL, numbers at the iso-
boles are the values of the effect to which they correspond. CdS-NPs
indicates cadmium sulfide nanoparticles; MeS-NP, mercaptoethanesul-
fonate nanoparticle; PbS-NPs, lead sulphide nanoparticles.
Figure 12. Isobologram characterizing the combined toxic action of
CdS-NPs andPbS-NPson theHL-1 cells culture as estimatedbydecrease
in adenosine triphosphate–dependent luminescence. Numbers at the
axes are respective MeS-NP concentrations in mg/mL, numbers at the
isoboles are the values of the effect to which they correspond. CdS-NPs
indicates cadmium sulfide nanoparticles; MeS-NP, mercaptoethanesulfo-
nate nanoparticle; PbS-NPs, lead sulphide nanoparticles.
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hormesis models that we found in the literature. Overall, these
results suggest that it would be scientifically reasonable to
expand the concept of hormesis further by incorporating into
it the possibility of several alternating changes in the sign of the
response in any sequence. A possible essential mechanism of 3-
phase “dose–response” relationships (which in this study were
found to be typical of PbS-NP) is hypothesized.
Further support has been obtained for the fact that the ambi-
guity of the type of action displayed by one and the same pair of
agents should be considered as one of the postulates of the
general theory of combined toxicity.
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Notes
1. The ultrastructural signs of damage to these organelles have been
repeatedly shown (see, eg, overviews3,11) to be some of the most
pronounced ones. Although no mitochondrial stimulation phase in
response to the impact of any nanoparticles was discovered, it may
be admitted not only based on the general concept of hormesis but
also taking into consideration the probable importance of hormetic
effects caused by different mitochondrial stressors.69
2. This value is much higher compared with the IC50 of CdS-NPs
found in an experiment on HeLa cells to be 4 mg/mL.70
References
1. Ahamed M, Ali D, Alhadlaq HA, Akhtar MJ. Nickel oxide nano-
particles exert cytotoxicity via oxidative stress and induce apop-
totic response in human liver cells (HepG2). Chemosphere. 2013;
93(10):2514-2522. doi:10.1016/j.chemosphere.2013.09.047.
2. Alarifi S, Ali D, Alkahtani S. Oxidative stress-induced DNA
damage by manganese dioxide nanoparticles in human neuronal
cells. Biomed Res Int. 2017;2017:5478790. doi:10.1155/2017/
5478790.
3. Fro¨hlich E. Cellular targets and mechanisms in the cytotoxic
action of non-biodegradable engineered nanoparticles. Curr Drug
Metab. 2013;14(9):976-988. doi:10.2174/1389200211314090
004.
4. Horie M, Fukui H, Nishio K, et al. Evaluation of acute oxidative
stress induced by NiO nanoparticles in vivo and in vitro. J Occup
Health. 2011;53:64-74.
5. Hussain SM, Javorina AK, Schrand AM, Duhart EM, Ali SF,
Schlager JJ. The interaction of manganese nanoparticles with
PC-12 cells induces dopamine depletion. Toxicol Sci. 2006;92:
456-463. doi:10.1093/toxsci/kfl020.
6. Choi JY, Lee SH, Na HB, An K, Hyeon T, Seo TS. In vitro
cytotoxicity screening of water-dispersible metal oxide
nanoparticles in human cell lines. Bioprocess Biosyst Eng.
2010;33(1):21-30. doi:10.1007/s00449-009-0354-5.
7. Ivask A, Titma T, Visnapuu M, et al. Toxicity of 11 metal oxide
nanoparticles to three mammalian cell types in vitro. Curr Top
Med Chem. 2015;15:1914-1929.
8. Minigalieva IA, Bushueva TV, Fro¨hlich E, et al. Are in vivo and
in vitro assessments of comparative and combined toxicity of the
same metallic nanoparticles compatible, or contradictory, or
both? A juxtaposition of data obtained in some experiments with
NiO and Mn3O4 nanoparticles. Food Chem Toxicol. 2017;109(1):
393-404. doi:10.1016/j.fct.2017.09.032.
9. Bushueva TV, Minigalieva IA, Panov VG, et al. More data on in
vitro assessment of comparative and combined toxicity of metal
oxide nanoparticles. Food Chem Toxicol. 2019;133:110753. doi:
10.1016/j.fct.2019.110753.
10. Minigalieva IA, Katsnelson BA, Panov VG, et al. Experimental
study and mathematical modeling of toxic metals combined
action as a scientific foundation for occupational and environmen-
tal health risks assessment. A synthesis of results obtained by the
Ekaterinburg research team (Russia). Toxicol Rep. 2017;4:
194-201. doi:10.1016/j.toxrep.2017.04.002.
11. Katsnelson BA, Privalova LI, Sutunkova MP, et al. Experimental
research into metallic and metal oxide nanoparticle toxicity in
vivo. In: Yan B, Zhou H, Gardea-Torresdey J, eds. Bioactivity
of Engineered Nanoparticles. Berlin, Germany: Springer; 2017:
259-319. doi:10.1007/978-981-10-5864-6.
12. Klinova SV, Minigalieva IA, Privalova LI, et al. Further verifica-
tion of some postulates of the combined toxicity theory: new
animal experimental data on separate and joint adverse effects
of lead and cadmium. Food Chem Toxicol. 2020;136:11097.
doi:10.1016/j.fct.2019.110971.
13. Jawad H, Boccaccini AR, Ali NN, Harding SE. Assessment of
cellular toxicity of TiO2 nanoparticles for cardiac tissue engineer-
ing applications. Nanotoxicology. 2011;5(3):372-380. doi:10.
3109/17435390.2010.516844.
14. Ren M, Wang T, Huang L, Ye X, Han Z. Mesoporous silica
nanoparticles rescue H(2)O(2)-induced inhibition of cardiac dif-
ferentiation. Cell Struct Funct. 2018;43(2):109-117. doi:10.1247/
csf.18008.
15. Lin CX, Gu JL, Cao JM. The acute toxic effects of platinum
nanoparticles on ion channels, transmembrane potentials of car-
diomyocytes in vitro and heart rhythm in vivo in mice. Int J
Nanomed. 2019;14:5595-5609. doi:10.2147/IJN.S209135.
16. Narasimhan G, de Alba-Aguayo DR, Mondrago´n-Flores R, et al.
Acute administration of chitosan nanoparticles increases Ca2þ
leak in rat cardiomyocytes. J Nano Res. 2014;28:29-38. doi:10.
4028/www.scientific.net/jnanor.28.29
17. Bostan HB, Rezaee R, Valokala MG, et al. Cardiotoxicity of
nano-particles. Life Sci. 2016;165:91-99. doi:10.1016/j.lfs.2016.
09.017.
18. Guo GR, Chen L, Rao M, Chen K, Song JP, Hu SS. A modified
method for isolation of human cardiomyocytes to model cardiac
diseases. J Transl Med. 2018;16(1):288. doi:10.1186/s12967-018-
1649-6.
19. Parameswaran S, Kumar S, Verma RS, Sharma RK. Cardiomyo-
cyte culture – an update on the in vitro cardiovascular model and
12 Dose-Response: An International Journal
future challenges. Can J Physiol Pharmacol. 2013;91(12):
985-998. doi:10.1139/cjpp-2013-0161.
20. White SM, Constantin PE, Claycomb WC. Cardiac physiology at
the cellular level: use of cultured HL-1 cardiomyocytes for studies
of cardiac muscle cell structure and function. Am J Physiol Heart
Circ Physiol. 2004;286(3):H823-H829. doi:10.1152/ajpheart.
00986.2003.
21. Claycomb WC, Lanson NA Jr, Stallworth BS, et al. HL-1 cells: a
cardiac muscle cell line that contracts and retains phenotypic
characteristics of the adult cardiomyocyte. Proc Natl Acad Sci
U S A. 1998;95(6):2979-2984. doi:10.1073/pnas.95.6.2979.
22. Lo´pez-Andre´s N, In˜igo C, Gallego I, Dı´ez J, Fortun˜o MA. Aldos-
terone induces cardiotrophin-1 expression in HL-1 adult cardio-
myocytes. Endocrinology. 2008;149(10):4970-4978. doi:10.
1210/en.2008-0120.
23. Bloch L, Ndongson-Dongmo B, Kusch A, Dragun D, Heller R,
Huber O. Real-time monitoring of hypertrophy in HL-1 cardio-
myocytes by impedance measurements reveals different modes of
growth. Cytotechnology. 2016;68(5):1897-1907. doi:10.1007/
s10616-016-0001-3.
24. Peter AK, Bjerke MA, Leinwand LA. Biology of the cardiac
myocyte in heart disease. Mol Biol Cell. 2016;27(14):
2149-2160. doi:10.1091/mbc.E16-01-0038.
25. Protsenko YL, Katsnelson BA, Klinova SV, et al. Effects of sub-
chronic lead intoxication of rats on the myocardium contractility.
Food Chem. Toxicol. 2018;120:378-389. doi:10.1016/j.fct.2018.
07.0.
26. Guerrero-Beltra´n CE, Bernal-Ramı´rez J, Lozano O, et al. Silica
nanoparticles induce cardiotoxicity interfering with energetic sta-
tus and Ca(2þ) handling in adult rat cardiomyocytes. Am J Phy-
siol Heart Circ Physiol. 2017;312(4):H645-H661. doi:10.1152/
ajpheart.00564.2016.
27. Bers DM. Excitation-Contraction Coupling and Cardiac Con-
tractile Force. 2nd ed. Dordrecht/Boston/London: Kluwer Aca-
demic Publishers; 2001.
28. Eisner DA, Caldwell JL, Kistama´s K, Trafford AW. Calcium and
excitation–contraction coupling in the heart. Circulat Res. 2017;
121(2):181-195. doi:10.1161/circresaha.117.310230.
29. Gmyr V, Bonner C, Lukowiak B, et al. Automated digital image
analysis of islet cell mass using Nikon’s inverted eclipse Ti micro-
scope and software to improve engraftment may help to advance
the therapeutic efficacy and accessibility of islet transplantation
across centers. Cell Transplant. 2015;24(1):1-9. doi:10.3727/
096368913X667493.
30. Nagai H, Satomi T, Abiru A, et al. Antihypertrophic effects of
small molecules that maintain mitochondrial ATP levels under
hypoxia. EBioMedicine. 2017;24:147-158. doi:10.1016/j.ebiom.
2017.09.022.
31. Bootman MD, Rietdorf K, Collins T, Walker S, Sanderson M.
Ca2þ-sensitive fluorescent dyes and intracellular Ca2þ imaging.
Cold Spring Harb Protoc. 2013;2(1):83-99. doi:10.1101/pdb.
top066050.
32. Dinse GE, Umbach DM. Dose–response modeling. In: Rider C,
Simmons JE, eds. Chemical Mixtures and Combined Chemical
and Nonchemical Stressors. Berlin, Germany: Springer Interna-
tional Publishing AG; 2018:205-234.
33. Nelson DL, Cox MM. Lehninger Principles of Biochemistry. 6th
ed. New York, NY: WH. Freeman; 2013:158-162.
34. Kleiber C, Kotz S. Statistical Size Distributions in Economics and
Actuarial Sciences. Wiley Series in Probability and Statistics.
Hoboken, NJ: John Wiley & Sons, Inc; 2003.
35. Johnson KA. A century of enzyme kinetic analysis, 1913 to 2013.
FEBS Lett. 2013;587(17):2753-2766. doi:10.1016/j.febslet.2013.
07.012.
36. Lopez S, France J, Gerrits WJ, Dhanoa MS, Humphries DJ, Dijk-
stra J. A generalized Michaelis-Menten equation for the analysis
of growth. J Anim Sci. 2000;78(3):1816-1828. doi:10.2527/2000.
7871816x.
37. Neafsey PJ. A mathematical modeling approach to characterize
hormesis, caloric restriction and toxicity in mortality data from
toxicity studies. Am J Pharmacol Toxicol. 2008;3(1):80-92.
38. Calabrese EJ. The emergence of the dose–response concept in
biology and medicine. Int J Mol Sci. 2016;17(12):2034. doi:10.
3390/ijms17122034.
39. Clark AJ. Handbook of Experimental Pharmacology. Berlin:
Springer; 1937.
40. Calabrese EJ. Challenging dose–response dogma. Scientist Mag-
azine. 2005. https://www.the-scientist.com/vision/challenging-do
se-response-dogma-49062.
41. Mushak P. Limits to chemical hormesis as a dose–response model
in health risk assessment. Sci Total Environ. 2013;443:643-649.
doi:10.1016/j.scitotenv.2012.11.017.
42. Kendig EL, Le HH, Belcher SM. Defining hormesis: evaluation
of a complex concentration response phenomenon. Int J Toxicol.
2010;29(3):235-246. doi:10.1177/1091581810363012.
43. Southam CM, Ehrlich J. Effects of extract of Western red-cedar
heartwood on certain wood-decaying fungi in culture. Phyto-
pathology. 1943;33:517-524.
44. Tang S, Liang J, Xiang C, et al. A general model of hormesis in
biological systems and its application to pest management. J R
Soc Interface. 2019;16(157):20190468. doi:10.1098/rsif.2019.
0468.
45. Belz RB, Piepho HP. Statistical modeling of the hormetic dose
zone and the toxic potency completes the quantitative description
of hormetic dose responses. Environ Toxicol Chem. 2014;34(5):
1169-1177. doi:10.1002/etc.2857.
46. Radak Z, Ishihara K, Tekus E, et al. Exercise, oxidants, and anti-
oxidants change the shape of the bell-shaped hormesis curve.
Redox Biol. 2017;12:285-290. doi:10.1016/j.redox.2017.02.015.
47. Nweke CO, Ogbonna CJ. Statistical models for biphasic dose–
response relationships (hormesis) in toxicological studies. Eco-
toxicol Environ Contam. 2017;12(1):39-55. doi:10.5132/eec.
2017.01.06.
48. Huang YY, Sharma SK, Carroll J, Hamblin MR. Biphasic dose
response in low level light therapy – an update. Dose-Response.
2011;9(4):602-618. doi:10.2203/dose-response.11-009.Hamblin.
49. Brain P, Cousens R. An equation to describe dose responses
where there is stimulation of growth at low doses. Weed Res.
1989;29(5):93-96. doi:10.1111/J.1365-3180.1989.TB00845.X.
50. Cedergreen N, Ritz C, Streibig JC. Improved empirical models
describing hormesis. Environ Toxicol Chem. 2005;24(12):
3166-3172. doi:10.1897/05-014r.1.
Panov et al 13
51. Ritz C, Baty F, Streibig JC, Gerhard D. Dose–response analysis
using R. PLoS One. 2015;10(12):e0146021. doi:10.1371/journal.
pone.0146021.
52. Seber GAF, Wild CJ. Nonlinear Regression. Hoboken, NJ: John
Wiley & Sons; 2003.
53. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New
York, NY: Chapman & Hall; 1993.
54. Dybowski R. Assigning Confidence Intervals to Neural Network
Predictions, Technical Report. Division of Infection (St Thomas’
Hospital). London, UK: King’s College; 1993.
55. Penny WD, Roberts SJ. Neural Network Predictions with Error
Bars. Research Report TR-97-1. London, England: Department of
Electrical and Electronic Engineering, Imperial College; 1997.
56. Lee PM. Bayesian Statistics: An Introduction. 2nd ed. London,
UK: Edward Arnold; 1997.
57. The R Project for Statistical Computing. https://cran.r-project.
org/. Accessed March, 2020.
58. Varaksin AN, Katsnelson BA, Panov VG, et al. Some considera-
tions concerning the theory of combined toxicity: a case study of
subchronic experimental intoxication with cadmium and lead.
Food Chem Toxicol. 2014;64(2):144-156. doi:10.1016/j.toxrep.
2017.04.002.
59. Panov VG, Katsnelson BA, Varaksin AN, et al. Further develop-
ment of mathematical description for combined toxicity: a case
study of lead–fluoride combination. Toxicol Rep. 2015;2(1):
297-307. doi:10.1016/j.toxrep.2015.02.002.
60. Box GEP, Draper NR. Response Surfaces, Mixtures, and Ridge
Analyses. Hoboken, NJ: John Wiley & Sons Inc; 2007.
61. Myers RH, Montgomery DC, Anderson-Cook CM. Response Sur-
face Methodology. Process and Product Optimization Using
Designed Experiments. 3rd ed. Hoboken, NJ: John Wiley & Sons
Inc; 2009.
62. Panov VG, Varaksin AN. Identification of combined action types
in experiments with two toxicants: a response surface linear
model with a cross term. Toxicol Mech Methods. 2016;26(2):
139-150. doi:10.3109/15376516.2016.1139023.
63. Chen ZI, Ai DI. Cardiotoxicity associated with targeted cancer
therapies. Mol Clin Oncol. 2016;4(5):675-681. doi:10.3892/mco.
2016.800.
64. Huang XP, Mangano T, Hufeisen S, Setola V, Roth BL. Identifi-
cation of human Ether-a`-go-go related gene modulators by three
screening platforms in an academic drug-discovery setting. Assay
Drug Dev Technol. 2010;8(6):727-742. doi:10.1089/adt.2010.
0331.
65. Calabrese EJ, Baldwin LA. A quantitatively-based methodology
for the evaluation of chemical hormesis. Hum Ecol Risk Assess.
1997;3(4):545-554. doi:10.1080/10807039709383710.
66. Calabrese EJ, Blain RB. The hormesis database: the occurrence of
hermetic dose responses in the toxicological literature. Regul Tox-
icol Pharm. 2011;61(1):73-81. doi:10.1016/j.yrtph.2011.06.003.
67. Choi VW, Yum EH, Konishi T, Oikawa M, et al. Triphasic low-
dose response in zebrafish embryos irradiated by microbeam pro-
tons. J Radiat Res. 2012;53(3):475-481.
68. Kong EY, Cheng SH, Yu KN. Biphasic and triphasic dose
responses in zebrafish embryos to low-dose 150 kV X-rays with
different levels of hardness. J Radiat Res. 2016;57(4):363-369.
doi:10.1093/jrr/rrw026.
69. Meyer JN, Hartman JH, Mello DF. Mitochondrial toxicity. Tox-
icol Sci. 2018;162(1):15-23. doi:10.1093/toxsci/kfy008.
70. Hossain ST, Mukherjee SK. Toxicity of cadmium sulfide (CdS)
nanoparticles against Escherichia coli and HeLa cells. J Hazard
Mater. 2013;260(15):1073-1082. doi:10.1016/j.jhazmat.2013.07.
005.
71. Minigalyeva IA, Katsnelson BA, Privalova LI, et al. Toxicody-
namic and toxicokinetic descriptors of combined chromium (VI)
and nickel toxicity. Int. J Toxicol. 2014;33(6):498-505 doi:10.
1177/1091581814555915.
72. Katsnelson BA, Panov VG, Minigaliyeva IA, et al. Further devel-
opment of the theory and mathematical description of combined
toxicity: an approach to classifying types of action of three-
factorial combinations (a case study of manganese-chromium-
nickel subchronic intoxication). Toxicology. 2015;334:33-44.
doi:10.1016/j.tox.2015.05.005.
73. Katsnelson BA, Minigalieva IA, Panov VG, et al. Some patterns
of metallic nanoparticles’ combined subchronic toxicity as exem-
plified by a combination of nickel and manganese oxide nanopar-
ticles. Food Chem Toxicol. 2015;86(2):351-364. doi:10.1016/j.
fct.2015.11.012.
74. Minigalieva IA, Katsnelson BA, Privalova LI, et al. Attenua-
tion of combined nickel(II) oxide and manganese(II, III) oxide
nanoparticles’ adverse effects with a complex of bioprotectors.
Int J Mol Sci. 2015;16(9):22555-22583. doi:10.3390/
ijms160922555.
75. Minigalieva IA, Katsnelson BA, Panov VG, et al. In vivo toxicity
of copper oxide, lead oxide and zinc oxide nanoparticles acting in
different combinations and its attenuation with a complex of
innocuous bioprotectors. Toxicology. 2017;380:72-93. doi:10.
1016/j.tox.2017.02.007.
76. Minigalieva IA, Katsnelson BA, Privalova LA, et al. Combined
subchronic toxicity of aluminum (III), titanium (IV) and silicon
(IV) oxide nanoparticles and its alleviation with a complex of
bioprotectors. Int J Mol Sci. 2018;19(3):E837. doi:10.3390/
ijms19030837.
14 Dose-Response: An International Journal
